BIRC2 amplification in squamous cell carcinomas of the uterine cervix

Virchows Archiv

Volumn 461, Issue 2, 2012, Pages 123-128

  Choschzick, M ^a   Tabibzada, A M ^a   Gieseking, F ^a   Woelber, L ^a   Jaenicke, F ^a   Sauter, G ^a   Simon, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Amplification; BIRC2; c IAP; Cervical carcinoma

Indexed keywords

BIRC2 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CHROMOSOME 11Q; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; TISSUE ARRAY ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84867404711     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1268-1     Document Type: Article

References (30)

1. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350 (Pubitemid 37328947)
2. Pett M, Coleman N (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212:356-367 (Pubitemid 47099012)
3. Hidalgo A, Baudis M, Petersen I et al (2005) Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer 5:77
4. Heselmeyer K, Schrock E, Du Manoir S et al (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 93:479-484 (Pubitemid 26038181)
5. Huang FY, Kwok YK, Lau ET et al (2005) Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet 157:42-48 (Pubitemid 40164857)
6. Wilting SM, Snijders PJ, Meijer GA et al (2006) Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 209:220-230 (Pubitemid 43805418)
7. Atkin NB (1997) Cytogenetics of carcinoma of the cervix uteri: a review. Cancer Genet Cytogenet 95:33-39 (Pubitemid 27188445)
8. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
9. Singh RK, Dasgupta S, Bhattacharya N et al (2005) Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol 131:395-406 (Pubitemid 40674625)
10. Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226-231
11. Imoto I, Tsuda H, Hirasawa A et al (2002) Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res 62:4860-4866 (Pubitemid 34984404)
12. Lockwood WW, Coe BP, Williams AC et al (2007) Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer 120:436-443 (Pubitemid 44956858)
13. Rothe M, Pan MG, Henzel WJ et al (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252 (Pubitemid 26007814)
14. Gagnon V, St-Germain ME, Parent S et al (2003) Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. Int J Oncol 23:803-810
15. Imoto I, Yang ZQ, Pimkhaokham A et al (2001) Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 61:6629-6634 (Pubitemid 32896476)
16. Dai Z, Zhu WG, Morrison CD et al (2003) A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum Mol Genet 12:791-801 (Pubitemid 36416965)
17. Sauter G, Simon R, Hillan K (2003) Tissue microarrays in drug discovery. Nat Rev Drug Discov 2:962-972 (Pubitemid 37540578)
18. Albertson DG (2006) Gene amplification in cancer. Trends Genet 22:447-455 (Pubitemid 44093770)
19. Kirchhoff M, Rose H, Petersen BL et al (1999) Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 24:144-150 (Pubitemid 29025260)
20. Wajant H, Scheurich P (2011) TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J 278:862-876
21. Zheng C, Yin Q, Wu H (2011) Structural studies of NF-kappaB signaling. Cell Res 21:183-195
22. Luo JL, Kamata H, Karin M (2005) IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115:2625-2632 (Pubitemid 41434385)
23. Karin M, Cao Y, Greten FR et al (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310 (Pubitemid 37328783)
24. Iwasawa A, Nieminen P, Lehtinen M et al (1996) Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 77:2275-2279 (Pubitemid 26162420)
25. Wagatsuma M, Hashimoto K, Matsukura T (1990) Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol 64:813-821 (Pubitemid 20032698)
26. Winder DM, Pett MR, Foster N et al (2007) An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol 213:27-34 (Pubitemid 47354563)
27. Thorland EC, Myers SL, Gostout BS et al (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22:1225-1237 (Pubitemid 36363386)
28. Cheung TH, Yu MM, Lo KW et al (2001) Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 166:199-206 (Pubitemid 32322666)
29. Carreras R, Alameda F, Mancebo G et al (2007) A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix. Histol Histopathol 22:587-592 (Pubitemid 46647271)
30. Bae DS, Cho SB, Kim YJ et al (2001) Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81:341-347